Bioavailability: Difference between revisions
From WikiLectures
(minor) |
No edit summary |
||
(3 intermediate revisions by one other user not shown) | |||
Line 6: | Line 6: | ||
*The route with the highest F (F=1) is via intravenous (I.V.) administration. | *The route with the highest F (F=1) is via intravenous (I.V.) administration. | ||
*The second highest F is achieved through inhalation. | *The second highest F is achieved through inhalation. | ||
*The parenteral routes of drug administration have low F because all the drug absorbed by the GIT, passes through the hepatic circulation undergoing | *The parenteral routes of drug administration have low F because all the drug absorbed by the GIT, passes through the hepatic circulation undergoing first pass metabolism, prior entering to the systemic circulation. | ||
'''<big>Types</big>''' | '''<big>Types</big>''' | ||
'''Absolute bioavailability''' | '''Absolute bioavailability''' | ||
[[File:AUC_IVPO.svg| right | 250px |]] | [[File:AUC_IVPO.svg| right|250px|The plasma concentration (C) over time (t) graph]] | ||
:It is the comparison of the per os F to the intravenous F | :It is the comparison of the per os F to the intravenous F | ||
::<math> {F_{abs}} = {AUC_{P.O.} \times D_{I.V.}\over AUC_{I.V.}\times D_{P.O.}} </math> | ::<math> {F_{abs}} = {{AUC_{P.O.} \times D_{I.V.}\over AUC_{I.V.}\times D_{P.O.}}\times 100 } </math> | ||
:where | :where | ||
::'''AUC<sub>P.O.</sub>''': area under the curve for the oral route | ::'''AUC<sub>P.O.</sub>''': area under the curve for the oral route | ||
Line 22: | Line 22: | ||
'''Relative bioavailability''' | '''Relative bioavailability''' | ||
:It is the comparison of the per os F to another administration route, other than intravenous. | :It is the comparison of the per os F to another administration route, other than intravenous. | ||
[[category: pharmacology]] |
Latest revision as of 19:24, 14 February 2024
Definition
- Bioavailability (F) is a pharmacokinetic parameter representing the fraction of a drug dose that reaches the systemic circulation unaltered.
Characteristics
- The greater the F, the greater the amount of drug that reaches the systemic circulation, and thus the greater the drug concentration in plasma and vice versa
- The route with the highest F (F=1) is via intravenous (I.V.) administration.
- The second highest F is achieved through inhalation.
- The parenteral routes of drug administration have low F because all the drug absorbed by the GIT, passes through the hepatic circulation undergoing first pass metabolism, prior entering to the systemic circulation.
Types
Absolute bioavailability
- It is the comparison of the per os F to the intravenous F
- where
- AUCP.O.: area under the curve for the oral route
- AUCI.V.: area under the curve for the intravenous route
- DP.O.: dose administered from oral route
- DI.V.: dose administers from intravenous route
Relative bioavailability
- It is the comparison of the per os F to another administration route, other than intravenous.